Showing results (571-580 of 586) with videos related to
Sort By:
Pageof 59
Clinical and Translational Science|July 18, 2015
CTSA Consortium Consensus Scientific Review Committee (SRC) Working Group Report on the SRC ProcessesHarry P Selker, John B Buse, Robert M Califf, et al.Circulation|December 28, 2018
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 TrialsAlexander C Fanaroff, Robert Clare, Karen S Pieper, et al.Heart Rhythm|May 29, 2026
The present and the future of risk stratification for and prevention of sudden cardiac death: A Heart Rhythm Society think tank meetingSana M Al-Khatib, Michael J Ackerman, Robert M Califf, et al.Journal of the American College of Cardiology|July 18, 2020
Precision Health Analytics With Predictive Analytics and Implementation Research: JACC State-of-the-Art ReviewThomas A Pearson, Robert M Califf, Rebecca Roper, et al.Circulation|October 22, 2019
Technology-Enabled Clinical Trials: Transforming Medical Evidence GenerationGuillaume Marquis-Gravel, Matthew T Roe, Mintu P Turakhia, et al.American Heart Journal|June 2, 2007
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policyGillian D Sanders, Sana M Al-Khatib, Elise Berliner, et al.JAMA|April 10, 2002
Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial, Jonathan RT Davidson, Kishore M Gadde, et al.Science Translational Medicine|July 31, 2020
Scientific considerations for global drug developmentJennifer L Wilson, Kit Wun Kathy Cheung, Lawrence Lin, et al.Journal of Thrombosis and Thrombolysis|May 7, 2011
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, BrazilRenato D Lopes, Richard C Becker, John H Alexander, et al.JAMA|July 9, 2004
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trialJames J Ferguson, Robert M Califf, Elliott M Antman, et al.Pageof 59